Previous Close | 0.2938 |
Open | 0.2938 |
Bid | 0.2113 x 200 |
Ask | 0.3819 x 200 |
Day's Range | 0.2888 - 0.3100 |
52 Week Range | 0.2700 - 1.0200 |
Volume | |
Avg. Volume | 3,055,468 |
Market Cap | 154.232M |
Beta (5Y Monthly) | 1.21 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.3100 |
Earnings Date | Aug 08, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 2.00 |
Collaboration to help increase awareness of the power of genetic testing when it comes to learning about personal health risksSUNNYVALE, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co., (Nasdaq: ME), a leading human genetics and preventive health company, today announced an ongoing collaboration with Mathew Knowles, father of Beyoncé and Solange Knowles, well-known entrepreneur, global leader in sales and marketing, and breast cancer survivor, to serve as a new global brand ambassa
Millions of people who bought DNA tests from genetic testing service 23andme have been urged to delete their personal data amid concerns about the company’s future.
23andMe has recently come under fire. What does that mean for its 15 million customers?